Our Mission is to Save Human Lives by
Early Detection of Heart Injury
Novel insights derived from a recently completed biomarker study that enrolled 840 individuals across 10 hospital locations in the United States highlighted
Highlights from a First-In-Human transdermal continuous monitoring reveal real-time biomarker trends from RCE’s wrist wearable
RCE showcases its novel technology towards a new era of biomarker monitoring and disease phenotyping
RCE’s innovative technology and roadmap were presented center stage alongside late breaking insights from recently conducted pre-clinical and clinical studies in cardiac catheterization labs.
Abstract highlighted for its potential, to detect cardiac injury, potentially altering evaluation of patients suspected for ACS, in community and emergency settings.
Dr. Frank Peacock, a distinguished figure in the medical community, shared his insights on a revolutionary point-of-care test, that can be leveraged to assess heart damage early
RCE.ai, an innovative health tech company, has been selected into the prestigious Cedars-Sinai Accelerator program
Carlsbad, California (May 1, 2023) – RCE Technologies, Inc. RCE’s technology was recognized in the cardiology research highlights from the review conducted and published in the world’s preeminent scientific journal Nature Reviews Cardiology. The review states the diagnosis of acute MI requires a rise and/or fall in the plasma level of cardiac troponins. The expert point of…
Carlsbad, California (April 24, 2023) – RCE Technologies, Inc. RCE’s technology was recently featured in the latest release of the globally acclaimed Journal of the American Medical Association (JAMA) magazine. The experts point of view was set in the perspective of current state of affairs in the emergency department setting with blood draws that could take…
Carlsbad, California (April 11, 2023) – RCE Technologies, Inc. Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When someone experiences a heart attack, it’s crucial to identify and treat it quickly to prevent further damage to the heart and increase the chances of survival.…
Carlsbad, California (May 1, 2023) – RCE Technologies, Inc. Esteemed editors at the European Heart Journal (EHJ) – Digital Health reviewed the recently published work ‘A novel breakthrough in wrist-worn transdermal troponin-I-sensor assessment for acute myocardial infarction’, by S. Sengupta et al., https://doi.org/10.1093/ehjdh/ztad015. The editors provide a remarkable perspective on the insights derived from the multi-center…
Carlsbad, California (March 27, 2023) – RCE Technologies, Inc. Check out the Professor Mamas Mamas’s recent interview with Dr. Partho Sengupta. Dr. Sengupta emphasizes the value of continuous biomarkers, the change in the reported values over time, and the future of integrating the technology beyond the emergency department. The interview can be found here: https://www.tctmd.com/videos/beyond-the-data-a-wristworn-sensor-in-chest-pain-workup.6321864168112 TCTMD…